In the realm of scientific communication, traditional posters serve as critical conduits for HCPs seeking the latest ...

G&L taps new hire to lead growth. G&L Healthcare Advisors, a Madison, New Jersey consultancy specialising in regulatory and ...

At the European Respiratory Society (ERS) congress in Vienna, Loes van Bemmel of Maastricht University Medical Center in the ...

The financing announcement came right after Terns reported phase 1 results with its oral GLP-1 receptor agonist TERN-601, ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of ...

Boehringer's zongertinib and Bayer's BAY 2927088 are in phase 3 testing for advanced non-small cell lung cancer (NSCLC) with ...

The US House of Representatives comprehensively voted in favour of the BIOSECURE Act, which will prohibit businesses in the ...

Chiesi has taken the lead in making an upfront investment in a new platform of inhalers, called the carbon minimal inhalers, ...

The Medtech sector is at a critical moment, where innovation and regulation must coexist. A stricter regulatory environment ...

Swiss start-up Haya Therapeutics has formed a partnership with Eli Lilly – worth up to $1 billion – to look for new therapies ...

MSD's PD-1 inhibitor Keytruda has ruled the immunotherapy of non-small cell lung cancer (NSCLC) for many years, but a ...

The Missouri case was detected through routine flu season surveillance, said the CDC, and is also the first time that an H5 ...